Global Myocardial Infarction (MI) Therapeutics Market 2024-2028

Myocardial Infarction (Mi) Therapeutics Market 2024-2028


The myocardial infarction (Mi) therapeutics market is forecasted to grow by USD 1925.6 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the myocardial infarction (Mi) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of mi, increased adoption of novel antithrombotics, and favorable reimbursement schemes.

Technavio's myocardial infarction (Mi) therapeutics market is segmented as below:
  • By Product
  • Antithrombotics
  • Vasodilators
  • Thrombolytics
  • Others
  • By Geographical Landscape
  • North America
  • Asia
  • Europe
  • Rest of World (ROW)
This study identifies the increasing risk factors for mi as one of the prime reasons driving the myocardial infarction (Mi) therapeutics market growth during the next few years. Also, advanced diagnostic modalities for mi and rising number of patient-support initiatives will lead to sizable demand in the market.

The report on the myocardial infarction (Mi) therapeutics market covers the following areas:
  • Myocardial Infarction (Mi) Therapeutics Market sizing
  • Myocardial Infarction (Mi) Therapeutics Market forecast
  • Myocardial Infarction (Mi) Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading myocardial infarction (Mi) therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Athera Biotechnologies AB, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., CeleCor Therapeutics, CHIESI Farmaceutici SpA, CSL Ltd., Eli Lilly and Co., Ever Supreme Bio Technology, F. Hoffmann La Roche Ltd., Faraday Pharmaceuticals, Idorsia Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Merck and Co. Inc., Mesoblast Ltd., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the myocardial infarction (Mi) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Myocardial Infarction (MI) Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Myocardial Infarction (MI) Therapeutics Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Antithrombotics - Market size and forecast 2023-2028
Chart on Antithrombotics - Market size and forecast 2023-2028 ($ million)
Data Table on Antithrombotics - Market size and forecast 2023-2028 ($ million)
Chart on Antithrombotics - Year-over-year growth 2023-2028 (%)
Data Table on Antithrombotics - Year-over-year growth 2023-2028 (%)
6.4 Vasodilators - Market size and forecast 2023-2028
Chart on Vasodilators - Market size and forecast 2023-2028 ($ million)
Data Table on Vasodilators - Market size and forecast 2023-2028 ($ million)
Chart on Vasodilators - Year-over-year growth 2023-2028 (%)
Data Table on Vasodilators - Year-over-year growth 2023-2028 (%)
6.5 Thrombolytics - Market size and forecast 2023-2028
Chart on Thrombolytics - Market size and forecast 2023-2028 ($ million)
Data Table on Thrombolytics - Market size and forecast 2023-2028 ($ million)
Chart on Thrombolytics - Year-over-year growth 2023-2028 (%)
Data Table on Thrombolytics - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.5 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 Mexico - Market size and forecast 2023-2028
Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Chart on Mexico - Year-over-year growth 2023-2028 (%)
Data Table on Mexico - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
11.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
11.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
11.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
11.7 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
11.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.9 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
11.10 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.11 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.12 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Myocardial Infarction (MI) Therapeutics Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Antithrombotics - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Antithrombotics - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Antithrombotics - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Antithrombotics - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Vasodilators - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Vasodilators - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Vasodilators - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Vasodilators - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Thrombolytics - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Thrombolytics - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Thrombolytics - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Thrombolytics - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Product ($ million)
Exhibits51: Data Table on Market opportunity by Product ($ million)
Exhibits52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits53: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits54: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits55: Chart on Geographic comparison
Exhibits56: Data Table on Geographic comparison
Exhibits57: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits93: Market opportunity By Geographical Landscape ($ million)
Exhibits94: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits95: Impact of drivers and challenges in 2023 and 2028
Exhibits96: Overview on criticality of inputs and factors of differentiation
Exhibits97: Overview on factors of disruption
Exhibits98: Impact of key risks on business
Exhibits99: Companies covered
Exhibits100: Matrix on companies position and classification
Exhibits101: Amgen Inc. - Overview
Exhibits102: Amgen Inc. - Product / Service
Exhibits103: Amgen Inc. - Key news
Exhibits104: Amgen Inc. - Key offerings
Exhibits105: AstraZeneca Plc - Overview
Exhibits106: AstraZeneca Plc - Product / Service
Exhibits107: AstraZeneca Plc - Key news
Exhibits108: AstraZeneca Plc - Key offerings
Exhibits109: Bayer AG - Overview
Exhibits110: Bayer AG - Business segments
Exhibits111: Bayer AG - Key news
Exhibits112: Bayer AG - Key offerings
Exhibits113: Bayer AG - Segment focus
Exhibits114: Bristol Myers Squibb Co. - Overview
Exhibits115: Bristol Myers Squibb Co. - Product / Service
Exhibits116: Bristol Myers Squibb Co. - Key news
Exhibits117: Bristol Myers Squibb Co. - Key offerings
Exhibits118: Eli Lilly and Co. - Overview
Exhibits119: Eli Lilly and Co. - Product / Service
Exhibits120: Eli Lilly and Co. - Key offerings
Exhibits121: F. Hoffmann La Roche Ltd. - Overview
Exhibits122: F. Hoffmann La Roche Ltd. - Business segments
Exhibits123: F. Hoffmann La Roche Ltd. - Key news
Exhibits124: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits125: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits126: Merck and Co. Inc. - Overview
Exhibits127: Merck and Co. Inc. - Business segments
Exhibits128: Merck and Co. Inc. - Key news
Exhibits129: Merck and Co. Inc. - Key offerings
Exhibits130: Merck and Co. Inc. - Segment focus
Exhibits131: Novartis AG - Overview
Exhibits132: Novartis AG - Business segments
Exhibits133: Novartis AG - Key news
Exhibits134: Novartis AG - Key offerings
Exhibits135: Novartis AG - Segment focus
Exhibits136: Pfizer Inc. - Overview
Exhibits137: Pfizer Inc. - Product / Service
Exhibits138: Pfizer Inc. - Key news
Exhibits139: Pfizer Inc. - Key offerings
Exhibits140: Sanofi SA - Overview
Exhibits141: Sanofi SA - Business segments
Exhibits142: Sanofi SA - Key news
Exhibits143: Sanofi SA - Key offerings
Exhibits144: Sanofi SA - Segment focus
Exhibits145: Inclusions checklist
Exhibits146: Exclusions checklist
Exhibits147: Currency conversion rates for US$
Exhibits148: Research methodology
Exhibits149: Information sources
Exhibits150: Data validation
Exhibits151: Validation techniques employed for market sizing
Exhibits152: Data synthesis
Exhibits153: 360 degree market analysis
Exhibits154: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings